Glenmark receives two ANDA approvals from the FDA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Mar, 2016
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...Read more
Researchers working on new drug for Lupus
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 20 Jul, 2012
Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...Read more
Stem cell therapy effective in liver cirrhosis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2012
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...Read more
Old drug gives hope for new treatment in autism
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...Read more
Boehringer, Swiss institute collaborate on diabetes and obesity research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2012
Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and H...Read more
Omega-3 can reduce brain problems after stroke
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013
Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride...Read more
KHK advances DsiRNA cancer target, pays $5 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2013
Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...Read more
Celgene halts phase III trial of cancer drug Revlimid
Drug Discovery | Regulatory | By BioSpectrum Bureau | 2 Comment | 19 Jul, 2013
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...Read more
BMS seeks Hep C therapy approval in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices...Read more
Daiichi US appoints Glenn Gormley as chairman
Drug Discovery | Influencers | By BioSpectrum Bureau | 3 Comment | 04 Oct, 2013
Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley w...Read more
Singapore nod for BMS, Pfizer heart drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Nov, 2013
Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by phar...Read more
Aus firm to raise $10 mn for multiple sclerosis drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Nov, 2013
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...Read more
WuXi PharmaTech partners with Pharmacyclics
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Nov, 2013
Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnolo...Read more
BHR expands brain injury treatment trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2012
Singapore: BHR Pharma has started recruiting patients, who are suffering from severe traumatic brain injury (TBI), for t...Read more
Astellas, Ambit Biosciences begin quizartinib trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Singapore: Japan-headquartered Astellas Pharma and Ambit Biosciences have initiated the phase IIb open-label clinical tr...Read more
Drug Discovery | Influencers | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Sample preparation is a daily function in any life science research or drug discovery lab and pipetting is a fundamental...Read more
Bayer stops haemophilia trial amidst drug safety concern
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 May, 2013
Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain...Read more
Boehringer seeks EU marketing nod for cancer drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 18 Oct, 2013
Singapore: Boehringer Ingelheim has submitted a marketing authorization application to the European Medicines Agency (EM...Read more